Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Triple-drug pharmacotherapy for cannabis dependence
ACTRN12609000581268Phase 3Not yet recruiting
- Sponsor
- St Vincent's Hospital Melbourne
- Start
- Aug 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial of tiagabine, acamprosate and mirtazapine in cannabis use disorder (CUD), sponsored by St Vincent's Hospital Melbourne. Primary endpoint: Proportion of patients achieving and maintaining abstinence from cannabis. Planned start Aug 2009; status: not yet recruiting.
02
Drugs
tiagabineacamprosatemirtazapine
03
Conditions
cannabis use disorder (CUD)
Beyond the preview
Go deeper on ACTRN12609000581268.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12609000581268.